Contemporary use of disease‐modifying drugs in the management of patients with early rheumatoid arthritis in Norway
Author:
Publisher
Informa UK Limited
Subject
Immunology,General Medicine,Immunology and Allergy,Rheumatology
Link
http://www.tandfonline.com/doi/pdf/10.1080/03009740802609566
Reference39 articles.
1. Early rheumatoid arthritis
2. A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis
3. The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Presence of Autoantibodies in Males and Females With Rheumatoid Arthritis: A Systematic Review and Metaanalysis;The Journal of Rheumatology;2022-03-15
2. Clinical effectiveness and safety of leflunomide in inflammatory arthritis: a report from the RAPPORT database with supporting patient survey;Clinical Rheumatology;2017-05-27
3. Safety of disease-modifying antirheumatic drugs and biologic agents for rheumatoid arthritis patients in real-life conditions;Seminars in Arthritis and Rheumatism;2015-04
4. Comparison of characteristics of international and national databases for rheumatoid arthritis: a systematic literature review;Scandinavian Journal of Rheumatology;2014-06-05
5. Evidence of the symptomatic and structural efficacy of methotrexate in daily practice as the first disease-modifying drug in rheumatoid arthritis despite its suboptimal use: results from the ESPOIR early synovitis cohort;Rheumatology;2012-06-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3